Heron Therapeutics, Inc. (HRTX)

Nasdaq: HRTX · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 1994

Grade4.3

◀ Past 5.2● Present 4.3▶ Future 3.7

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Feb 26, 2026	Feb 27, 2025	Mar 12, 2024	Mar 29, 2023	Feb 28, 2022	Feb 24, 2021	Mar 2, 2020	Feb 22, 2019	Feb 27, 2018	Feb 23, 2017
Revenue	154,904	144,285	127,044	107,672	86,346	88,638	145,968	77,474	30,767	1,279
Cost of revenue	41,347	38,648	65,105	54,874	46,021	36,189	61,619	27,512	4,588	35
Gross profit	113,557	105,637	61,939	52,798	·	·	·	·	·	·
Research and development	12,429	16,683	39,133^r	82,704^r	130,821	174,533	167,382	140,032	138,582	103,125
Sales and marketing	49,061	47,085	67,643	82,513	87,179	63,853	89,764	64,604	56,601	47,668
General and administrative	54,605	53,397	65,778^r	62,239^r	40,153	42,226	37,897	29,263	25,554	21,366
Total operating expenses	·	·	·	·	·	·	·	261,411	225,325	172,194
Total costs and expenses	116,095	117,165	172,554	227,456^r	304,174	316,801	356,662	261,411	225,325	·
Operating income	-2,538	-11,528	-110,615	-174,658	-217,828	-228,163	-210,694	-183,937	-194,558	-170,915
Interest expense	9,605	6,032	3,868	2,474	2,410	1,901	1,472	2,672	3,937	2,664
Interest and investment income	1,948	3,550	3,364	1,638	433	3,633	7,259	5,965	1,049	445
Other income (expense), net	1,339	430	560	-6,530	-878	-847	158	1,804	-38	-9^r
Total non-operating income (expense)	-17,657	-2,052	56	-7,366	-2,855	885	5,945	5,097	-2,926	-2,228
Income tax expense	0	0	0	0	0	0	0	0	0	0
Net income including non-controlling interests	-20,195	-13,580	-110,559	·	·	·	·	·	·	·
Net income	-20,195	-13,580	-110,559	-182,024	-220,683	-227,278	-204,749	-178,840	-197,484	-173,143
Earnings per share, basic	-0.12	-0.09	-0.80	-1.67	-2.24	·	·	·	·	·
Earnings per share, diluted	-0.12	-0.09	-0.80	-1.67	-2.24	·	·	·	·	·
Earnings per share, basic and diluted	·	·	·	·	-2.24	-2.50	-2.50	-2.44	-3.65	-4.56
Weighted average shares, basic	166,707,000	152,449,000	138,135,000	108,876,000^r	98,471	·	·	·	·	·
Weighted average shares, diluted	166,707,000	152,449,000	138,135,000	108,876,000^r	98,471,000^b	·	·	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	98,471,000	90,774,000	81,779,000	73,193,000	54,040,000	37,925,000

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:SalesRevenueGoodsNet

Cost of revenue what it cost to make or buy what it sold

us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton HRTX · research, not advice